Patients undergoing surgery of elbow,
Conditions
Interventions
guided axillary brachial plexus blockade use 0.5% Marcaine 15 milliliter + 2% Xylocaine plain 15 milliliter + Adrenalin 150 microgram,ultrasound-
guided axillary brachial plexus blockade use 0.5% Marcaine 15 milliliter + 2% Xylocaine plain 15 milliliter + Adrenalin 150 microgram + Dexamethazone 4 milligram,ultrasound-
guided axillary brachial plexus blockade use 0.5% Marcaine 15 milliliter + 2% Xylocaine plain 15 milliliter + Adrenalin 150 microgram + Morphine 5 milligram
Experimental Drug,Experimental Drug,Experimental Drug
placebo,Dexamethazone,Morphine
Sponsors
Kokha hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients aged more than 18 years - American Soceity of Anesthesiologist class I to III
Exclusion criteria
Exclusion criteria: - Uncooperative patient - Coagulopathy - History of allergy of bupivacaine, dexamethasone or morphine - Infection at the site of puncture for the block
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative pain at 0, 6, 12, 24 postoperative hour numerical rating scale | — |
Secondary
| Measure | Time frame |
|---|---|
| total postoperative opioid consumption postoperative period amount of opioid consumption,time to first postoperative opioid administration postoperative period time,duration of sensory block postoperative period patient report time to first pain,duration of motor block postoperative period patient report time to first move | — |
Countries
Thailand
Contacts
Public ContactKunchana Wiseskarn
Anesthesiology
Outcome results
None listed